| P50 | author | Carlo Maria Croce | Q640381 |
| P2093 | author name string | Veronica Balatti | |
| | Lara Rizzotto | |
| | Yuri Pekarky | |
| P2860 | cites work | Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation | Q24316905 |
| | Identification of the TCL1 gene involved in T-cell malignancies | Q24336607 |
| | miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 |
| | Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 |
| | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| | A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 |
| | MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias | Q24564008 |
| | 13q14 deletions in CLL involve cooperating tumor suppressors | Q24618669 |
| | MicroRNAs in mouse models of lymphoid malignancies | Q24618980 |
| | Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia | Q24633394 |
| | MiR-15a and miR-16-1 cluster functions in human leukemia | Q24647555 |
| | Tcl1 enhances Akt kinase activity and mediates its nuclear translocation | Q24670140 |
| | Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice | Q24675006 |
| | Cancer statistics, 2010 | Q27860525 |
| | The functions of animal microRNAs | Q27860621 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 |
| | The protooncogene TCL1 is an Akt kinase coactivator | Q28138483 |
| | Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation | Q28139187 |
| | Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 |
| | B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions | Q28201835 |
| | Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus | Q28203437 |
| | Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia | Q28206302 |
| | Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene | Q28216381 |
| | Chronic lymphocytic leukemia | Q28236621 |
| | microRNA involvement in human cancer | Q28264087 |
| | The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia | Q28269786 |
| | A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 |
| | Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181 | Q28279673 |
| | A microRNA component of the p53 tumour suppressor network | Q28305330 |
| | miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities | Q28307338 |
| | Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway | Q28615706 |
| | Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 |
| | TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 |
| | An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 |
| | The Bcl2 family: regulators of the cellular life-or-death switch | Q29614982 |
| | Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 |
| | MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing | Q29619773 |
| | MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia | Q33333245 |
| | In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells | Q33830733 |
| | Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest | Q48078984 |
| | Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. | Q50893928 |
| | MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. | Q53341906 |
| | APRIL promotes B-1 cell-associated neoplasm. | Q53364137 |
| | Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection. | Q54318362 |
| | Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 |
| | Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients | Q73068687 |
| | When and how to treat chronic lymphocytic leukemia | Q73291688 |
| | TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival | Q73925277 |
| | Characterization of a novel B-CLL candidate gene--DLEU7--located in the 13q14 tumor suppressor locus | Q75224028 |
| | Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia | Q78247896 |
| | miR-34a as part of the resistance network in chronic lymphocytic leukemia | Q79674968 |
| | The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish | Q80291687 |
| | TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state | Q81600853 |
| | 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation | Q82081731 |
| | microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia | Q82589392 |
| | Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia | Q84484644 |
| | MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. | Q33942272 |
| | Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression | Q33982310 |
| | Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression | Q34068006 |
| | Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia | Q34128395 |
| | Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation | Q34245495 |
| | All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction | Q34543653 |
| | Cell cycle deregulation in B-cell lymphomas. | Q34977269 |
| | BAFF AND APRIL: a tutorial on B cell survival | Q34994661 |
| | miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia | Q35220412 |
| | Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL) | Q35787000 |
| | MicroRNAs in vertebrate development | Q36175229 |
| | Chronic lymphocytic leukemia: molecular genetics and animal models | Q36329120 |
| | Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia | Q36350493 |
| | Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. | Q36530420 |
| | Possible immunoregulatory role for CD5+B cells | Q36589501 |
| | Animal models for chronic lymphocytic leukemia | Q36666648 |
| | Regulatory mechanisms of microRNAs involvement in cancer | Q36897389 |
| | Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells | Q36914065 |
| | The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia | Q36914074 |
| | Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia | Q36948708 |
| | Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. | Q37018730 |
| | microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival | Q37027816 |
| | Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications | Q37152757 |
| | Differential effects of Bcl-2 on T and B cells in transgenic mice | Q37321476 |
| | Karyotype-specific microRNA signature in chronic lymphocytic leukemia | Q37412319 |
| | TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice | Q37692413 |
| | p53-mediated activation of miRNA34 candidate tumor-suppressor genes. | Q40102003 |
| | Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. | Q40123066 |
| | Hematopoietic-specific microRNA expression in human cells | Q40361902 |
| | Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival | Q40877833 |
| | Is miR-29 an oncogene or tumor suppressor in CLL? | Q42006994 |
| | Genetic lesions in chronic lymphocytic leukemia: what's ready for prime time use? | Q42938336 |
| | CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation | Q43091453 |
| | Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome. | Q44041908 |
| | ZAP-70 expression and prognosis in chronic lymphocytic leukaemia | Q44730335 |
| | ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia | Q46112511 |
| | Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. | Q46944917 |
| | An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells | Q47909804 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 309-325 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | miR deregulation in CLL. | |
| P478 | volume | 792 | |